Comparison of Laboratory Results and Chest Computed Tomography Scans of COVID-19 Patients: A Pilot Study

In this article, we aimed to investigate lung involvement in patients suffering from the new Coronavirus Disease 2019 (COVID-19) and determine laboratory markers that indicate involvement. Patients diagnosed with COVID-19 pneumonia were included 90 patient Group 1, while 2 comprised 60 control group total of 150 patient. CCT scans study transferred Intrasense Myrian® software (Myrian;Intrasense, Montpellier, France) 3D models data generated. Mean levels D-dimer, fibrinogen C-reactive protein (CRP) 1 515±958 μg/L, 467±182 mg/dL 5.67±5.46 mg/dL, respectively, whereas those 129±120 345±113 1.32±2.58 respectively (P<0.001). Right volume (RLV), left (LLV) (TLV) 2419±554 cm3, 1857±634 cm3 3929±1297 measurements 2483±503 2118±535 4538±1079 Reduction volumes correlates increase D-dimer CRP decrease lymphocyte counts. Lung who develop Covid-19 decrease. these patients.